These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 10583705)

  • 21. Postprandial remnant lipoproteins as targets for the prevention of atherosclerosis.
    Nakajima K; Tanaka A
    Curr Opin Endocrinol Diabetes Obes; 2018 Apr; 25(2):108-117. PubMed ID: 29493553
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diurnal and acute patterns of postprandial apolipoprotein B-48 in VLDL, IDL, and LDL from normolipidemic humans.
    Campos H; Khoo C; Sacks FM
    Atherosclerosis; 2005 Aug; 181(2):345-51. PubMed ID: 16039289
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Consumption of diets with different type of fat influences triacylglycerols-rich lipoproteins particle number and size during the postprandial state.
    Perez-Martinez P; Ordovas JM; Garcia-Rios A; Delgado-Lista J; Delgado-Casado N; Cruz-Teno C; Camargo A; Yubero-Serrano EM; Rodriguez F; Perez-Jimenez F; Lopez-Miranda J
    Nutr Metab Cardiovasc Dis; 2011 Jan; 21(1):39-45. PubMed ID: 19819118
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Omega-3 fatty acids eicosapentaenoic acid and docosahexaenoic acid and their mechanisms of action on apolipoprotein B-containing lipoproteins in humans: a review.
    Oscarsson J; Hurt-Camejo E
    Lipids Health Dis; 2017 Aug; 16(1):149. PubMed ID: 28797250
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of a moderate exercise session on postprandial lipoproteins, apolipoproteins and lipoprotein remnants in middle-aged men.
    Gill JM; Al-Mamari A; Ferrell WR; Cleland SJ; Sattar N; Packard CJ; Petrie JR; Caslake MJ
    Atherosclerosis; 2006 Mar; 185(1):87-96. PubMed ID: 16024023
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of graded amounts (0-50 g) of dietary fat on postprandial lipemia and lipoproteins in normolipidemic adults.
    Dubois C; Beaumier G; Juhel C; Armand M; Portugal H; Pauli AM; Borel P; Latgé C; Lairon D
    Am J Clin Nutr; 1998 Jan; 67(1):31-8. PubMed ID: 9440372
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Effect of PCSK9 Loss-of-Function Variants on the Postprandial Lipid and ApoB-Lipoprotein Response.
    Ooi TC; Krysa JA; Chaker S; Abujrad H; Mayne J; Henry K; Cousins M; Raymond A; Favreau C; Taljaard M; Chrétien M; Mbikay M; Proctor SD; Vine DF
    J Clin Endocrinol Metab; 2017 Sep; 102(9):3452-3460. PubMed ID: 28673045
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Triglyceride-rich lipoproteins and atherosclerosis, from fast to feast.
    Steiner G
    Ann Med; 1993 Oct; 25(5):431-5. PubMed ID: 8251140
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dietary cholesterol, cholesterol absorption, postprandial lipemia and atherosclerosis.
    Huff MW
    Can J Clin Pharmacol; 2003; 10 Suppl A():26A-32A. PubMed ID: 14571303
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The apolipoprotein CI content of triglyceride-rich lipoproteins independently predicts early atherosclerosis in healthy middle-aged men.
    Hamsten A; Silveira A; Boquist S; Tang R; Bond MG; de Faire U; Björkegren J
    J Am Coll Cardiol; 2005 Apr; 45(7):1013-7. PubMed ID: 15808756
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Atherogenic postprandial remnant lipoproteins; VLDL remnants as a causal factor in atherosclerosis.
    Nakajima K; Tanaka A
    Clin Chim Acta; 2018 Mar; 478():200-215. PubMed ID: 29307667
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Postprandial lipoproteins and the molecular regulation of vascular homeostasis.
    Botham KM; Wheeler-Jones CP
    Prog Lipid Res; 2013 Oct; 52(4):446-64. PubMed ID: 23774609
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Abnormalities in apo B-containing lipoproteins in diabetes and atherosclerosis.
    Tomkin GH; Owens D
    Diabetes Metab Res Rev; 2001; 17(1):27-43. PubMed ID: 11241889
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Cutting-edge research on the metabolism of remnant lipoproteins].
    Yamamura T; Ishigami M
    Rinsho Byori; 2010 Jun; 58(6):613-21. PubMed ID: 20662274
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Atherogenic nature of triglycerides, postprandial lipidemia, and triglyceride-rich remnant lipoproteins.
    Zilversmit DB
    Clin Chem; 1995 Jan; 41(1):153-8. PubMed ID: 7813071
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Postprandial metabolism of apolipoprotein B-48- and B-100-containing particles in type 2 diabetes mellitus: relations to angiographically verified severity of coronary artery disease.
    Mero N; Malmström R; Steiner G; Taskinen MR; Syvänne M
    Atherosclerosis; 2000 May; 150(1):167-77. PubMed ID: 10781648
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Atherogenicity of triglyceride-rich lipoproteins.
    Krauss RM
    Am J Cardiol; 1998 Feb; 81(4A):13B-17B. PubMed ID: 9526808
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The rise and fall of postprandial lipids.
    Katan MB
    Neth J Med; 2004 Sep; 62(8):265-6. PubMed ID: 15588065
    [TBL] [Abstract][Full Text] [Related]  

  • 39. All ApoB-containing lipoproteins induce monocyte chemotaxis and adhesion when minimally modified. Modulation of lipoprotein bioactivity by platelet-activating factor acetylhydrolase.
    Lee C; Sigari F; Segrado T; Hörkkö S; Hama S; Subbaiah PV; Miwa M; Navab M; Witztum JL; Reaven PD
    Arterioscler Thromb Vasc Biol; 1999 Jun; 19(6):1437-46. PubMed ID: 10364074
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Paraoxonase 1 (PON1) is present in postprandial chylomicrons.
    Fuhrman B; Volkova N; Aviram M
    Atherosclerosis; 2005 May; 180(1):55-61. PubMed ID: 15823275
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.